EarningsQ2 2026 Earnings Report
VEXTF Q2 2026 EPS Results
Actual EPS$0.00
Consensus EPS$0.00
Beat/MissMet expectations
One Year Ago EPS-$0.01
VEXTF Q2 2026 Revenue Results
Actual Revenue$11.77M
Expected Revenue$12.30M
Beat/MissMissed by -$526.25K
YoY Revenue Growth-9.60%
Earnings Announcement Details
QuarterQ2 2026
Date08/20/2026
TimeAfter Close
Conference CallThursday, August 20, 2026
VEXTF Upcoming Earnings
Vext Science's next earnings date is estimated for December 1, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
VEXTF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized meaningful operational and margin improvements driven by Ohio execution and higher cultivation yields, alongside successful financing and balance sheet progress. These positives were balanced against a lower top line (driven by a planned Arizona cultivation wind-down), ongoing market weakness in Arizona, a significant uncertain tax liability, and modest reported operating cash flow due to deliberate inventory and payable timing. Management communicated a clear strategy to redeploy capital from Arizona to Ohio and to pay down debt, and they reported concrete near-term actions and improving trends.Company Guidance
Improved Profitability and Margins
Gross profit rose to $6.7M from $4.9M a year ago and gross margin expanded to 55% (vs 36% prior year). Even before fair-value adjustments, margin improved to ~44% from ~39% year-over-year.
Adjusted EBITDA Growth
Adjusted EBITDA was $3.4M, up 22% sequentially from $2.8M, with adjusted EBITDA margin improving to 28% from 23%.
Material Narrowing of Net Loss
Net loss narrowed to $0.3M in Q2 from $1.5M a year ago — an improvement of roughly 80% (about $1.2M).
Ohio: Primary Growth Engine
Ohio sales and operations grew: statewide Ohio sales were up ~28% in the first half of the year (state data). Opened the sixth dispensary (Fairfield) in June which is ramping, and a seventh Columbus dispensary is planned to open in Q1 FY27 under a dual-use license.
Significant Yield and Inventory Progress
Cultivation yields improved, now eclipsing 100 grams per plant for the first time; yield per plant is up ~68% over the last 2.5 years. Management intentionally built ~$2M of Ohio inventory in Q2 to supply retail growth and reports Ohio wholesale set a new monthly record in July.
Balance Sheet and Financing Actions
Completed a ~$17M financing with Wright-Patt Credit Union (gross proceeds) used to refinance ~$10.5M debt, acquire Jackson, OH facility for $6M, and fund Ohio expansion. Ended Q2 with ~$4.5M cash and remained in compliance with debt covenants. Net working capital improved from negative $11.7M at year-end to about negative $0.9M at Q2.
Strategic Asset Repositioning to Improve Capital Allocation
Eloy (Arizona cultivation property) reclassified as held for sale at $7.8M; expected net proceeds are earmarked to reduce secured debt and redeploy capital to higher-return Ohio operations.
VEXTF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed